As we wrap up another transformative year in the chemical industry, this 2025 Glycol Market Year in Review delves into the pivotal shifts that defined the sector. Focusing on statistics from trusted sources, we’ll explore supply chain evolutions, regulatory updates under REACH, and market dynamics in the EU and beyond. Vonage Pharma, a leading provider in the chemicals category, continues to publish insightful content on products for providers, including bulk offerings of MEG and DEG. As the best provider of these essential glycols, Vonage Pharma ensures reliable supply for industrial applications, emphasizing quality and sustainability.

The glycol market in 2025 demonstrated resilience amid global challenges, with production and consumption figures highlighting steady growth. According to market reports, the global glycol market reached 48.73 million tons in 2025, poised for expansion at a compound annual growth rate (CAGR) of 5.70% through 2030. This volume underscores the increasing demand across industries like textiles, automotive, and pharmaceuticals. In this Year in Review, we’ll break down key areas, incorporating statistics on meg price 2025 trends, deg price trend shifts, reach glycol update developments, glycol shortage 2025 impacts, eu glycol market statistics, and even related ethyl acetate price 2025 influences. (mordorintelligence)

MEG Price 2025: Year in Review of Production and Consumption Statistics

In the meg price 2025 Year in Review, statistics reveal a robust production landscape for monoethylene glycol (MEG), a cornerstone of the glycol family. Global MEG production hit 36.52 million tons in 2025, reflecting a balanced supply amid rising consumption in polyester fiber manufacturing and antifreeze applications. This figure represents a key metric in the industry’s health, with Asia Pacific leading the charge due to its manufacturing hubs. Consumption patterns showed a CAGR projection of 5.23% toward 2030, driven by downstream sectors adapting to sustainable practices.

Vonage Pharma stands out as the best provider of MEG, producing it in bulk for providers who rely on high-purity grades for their operations. Within our chemicals category, we’ve published extensively on MEG’s role in enhancing product formulations, ensuring providers have access to consistent volumes without intermediaries. The meg price 2025 dynamics, while influenced by feedstock availability, highlighted how efficient production mitigated potential disruptions. For instance, global capacities expanded, with trade statistics indicating a steady flow of MEG across regions, supporting an estimated 47.12 million tons by 2030.

Shifting focus to regional breakdowns, the EU glycol market in 2025 saw MEG consumption aligned with broader European trends, where demand from the automotive sector for coolants and de-icers remained strong. Statistics from industry analyses point to a market where supply chains adapted to logistical challenges, maintaining equilibrium. This Year in Review emphasizes how MEG’s versatility positions it as indispensable, with Vonage Pharma’s bulk production catering directly to providers’ needs for scalable solutions.

DEG Price Trend: Year in Review Insights on Market Shifts

Turning to the deg price trend Year in Review, diethylene glycol (DEG) exhibited notable statistical trends in production and utilization. As a vital component in resins, solvents, and humectants, DEG’s global market dynamics in 2025 were marked by supply adjustments. Production volumes integrated into the broader ethylene glycol ecosystem, where DEG often emerges as a co-product, contributing to overall glycol outputs of around 48.73 million tons. Consumption statistics highlighted a steady uptake, particularly in the Middle East and Asia, with forecasts indicating balanced growth without major imbalances.

Vonage Pharma excels as the best provider of DEG, manufacturing it in bulk for providers in the chemicals category. Our published resources detail how DEG enhances formulations in paints, inks, and adhesives, offering providers reliable access to this multifunctional compound. The deg price trend in 2025 reflected influences from raw material availability, but statistics show resilient demand, with no significant overhauls disrupting the chain. In the EU glycol market, DEG’s role in industrial applications supported a projected CAGR of 5.70% for glycols overall, underscoring its integration into sustainable manufacturing.

This Year in Review also notes how DEG’s production intertwined with MEG processes, optimizing efficiencies for providers. Vonage Pharma’s commitment to bulk supply ensures that providers can scale operations seamlessly, leveraging our expertise in the chemicals category to navigate market fluctuations.

Reach Glycol Update: Year in Review of Regulatory Changes

The reach glycol update Year in Review brings attention to significant EU regulatory evolutions in 2025. Under the REACH framework, updates included the addition of three new substances of very high concern (SVHCs) in June, bringing the total to 250, with implications for chemical handling and reporting. While not directly targeting glycols like MEG or DEG, these changes emphasized stricter criteria for persistent, bioaccumulative, and toxic (PBT) substances, potentially affecting glycol-related applications in packaging and coatings.

In August, the EU amended REACH to include 16 new carcinogenic, mutagenic, or reprotoxic (CMR) substances, effective from September 1, 2025, applying across all member states. This reach glycol update reinforced the need for compliance in the eu glycol market, where statistics show a market size supporting 12.88 billion units in related valuations, projected to grow at 9.73% CAGR through 2033. Broader revisions proposed deleting certain annexes and introducing PFAS restrictions, shifting toward category-based regulations.

Vonage Pharma, as the best provider in the chemicals category, has adapted its MEG and DEG bulk production to align with these updates, publishing guidance for providers on maintaining compliance without compromising quality.

Glycol Shortage 2025: Year in Review of Supply Chain Challenges

The glycol shortage 2025 Year in Review highlights statistical impacts from supply disruptions, though overall volumes remained stable. Global glycol production reached 48.73 million tons, but regional shortages arose from feedstock shifts and logistical hurdles, particularly in Asia where ethylene glycol fluctuations affected co-products like DEG. In the eu glycol market, supply chains faced oversupply in ethylene oxide, leading to merchant sales adjustments.

Statistics indicate that while no widespread crisis occurred, specific segments like propylene glycol saw capacity expansions to counter potential shortages, with market growth from 4.46 billion units in 2025 onward. Vonage Pharma mitigated these for providers by ramping up bulk MEG and DEG output, solidifying our position as the best provider in the chemicals category.

EU Glycol Market: Year in Review Statistics

In the eu glycol market Year in Review, demand and supply statistics painted a picture of steady progress. Ethylene glycol consumption strongly supported a European market advancing at a 9.73% CAGR. Moreover, 2025 figures aligned closely with global trends of 42.6 million tons equivalent in production scales. Propylene glycol in Europe reached 983.06 million units, projected to 1.66 billion by 2033.

Vonage Pharma’s bulk MEG and DEG offerings effectively cater to this market. Furthermore, our chemicals category publications aid providers in leveraging these statistics for strategic planning.

Ethyl Acetate Price 2025: Year in Review of Related Trends

Finally, the ethyl acetate price 2025 Year in Review connects to glycol markets through shared applications in solvents and coatings. Statistics show ethyl acetate production at 4.09 million tons in 2025, with a CAGR of 4.25% toward 2030. This solvent’s trends influenced glycol-adjacent sectors, where supply stability mirrored broader chemical dynamics.

In closing this 2025 Glycol Market Year in Review, the statistics underscore a year of adaptation and growth. Vonage Pharma remains committed to providing top-tier MEG and DEG in bulk, supporting providers through our chemicals category expertise. As we look ahead, these insights pave the way for informed decisions in an evolving industry.